The February 10th Market Update was generally accepted as being "good" by most posters on the forum.
It would be quite remarkable if the report was "bad" just 16 days later .... without a confession from the CEO.
- Forums
- ASX - By Stock
- Ann: Mayne Pharma enters Scheme Implementation Deed with Cosette
MYX
mayne pharma group limited
Add to My Watchlist
1.15%
!
$5.28

The February 10th Market Update was generally accepted as being...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.28 |
Change
0.060(1.15%) |
Mkt cap ! $426.5M |
Open | High | Low | Value | Volume |
$5.29 | $5.29 | $5.15 | $45.47K | 8.702K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 523 | $5.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.28 | 161 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 537 | 5.250 |
6 | 674 | 5.240 |
1 | 50 | 5.230 |
2 | 542 | 5.220 |
2 | 427 | 5.210 |
Price($) | Vol. | No. |
---|---|---|
5.270 | 1 | 1 |
5.280 | 225 | 1 |
5.290 | 1015 | 4 |
5.300 | 1805 | 3 |
5.310 | 400 | 2 |
Last trade - 11.57am 18/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online